BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Denator AB Appoints New Member to the Board


5/31/2011 1:24:29 PM

Gothenburg, Sweden, 30 May 2011: Denator AB announced today that Dr. Martin Nicklasson has been appointed as a new Board Member with immediate effect.

Dr Nicklasson has over 30 years’ experience in the pharmaceutical industry, holding senior executive management positions over the past 20 years such as CEO at Astra Zeneca AB,

Chairman of the board at Astra Tech and CEO at Biovitrum AB. Most recently, he served as President and CEO for Swedish Orphan Biovitrum AB (SOBI). Dr Nicklasson is currently a board member of, amongst others, the Swedish Heart & Lung Foundation, Scandinavian Life Science Invest AB and Biocrine AB.

Olof Sköld, CEO at Denator stated, “We are delighted to welcome Dr. Nicklasson to our Board. His extensive knowledge, experience and proven expertise in the pharmaceutical industry, one of our most important market segments, will be a very valuable addition to our company.”

About Denator AB

www.denator.com

Denator AB is a privately held biotech company based in Gothenburg, Sweden. Denator develops and markets products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. Based upon the company’s proprietary heat inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and so maintain the stability of sample components throughout the analytical workflow.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES